ArticleCureus2024
The Anatomical and Functional Outcome of Autologous Internal Limiting Membrane Transplant With 27-Gauge Vitrectomy in Failed and Recurrent Macular Holes in a Spectrum of Pathologies.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo describe the anatomical and functional outcome of autologous internal limiting membrane (ILM) transplant with 27-gauge plus (27G+) three ports pars plana vitrectomy (PPV) in failed and recurrent full-thickness macular holes (MH) in a spectrum of pathologies. STUDY
designObservational cohort study Methods: Seven eyes of seven patients who had failed or recurrent MH were included from January 2017 to January 2022. A single vitreoretinal surgeon performed all surgeries using a 27G+ PPV system in a tertiary care hospital. An autologous ILM transplant was performed in each case, using hexafluoroethane or perfluoropropane as tamponade agents. The primary outcomes encompassed achieving MH closure, determining the best possible vision achieved during the 12-month follow-up period, and assessing any post-operative complications.
resultsThe average age of the patients enrolled in this study was 49.4 years. Four of the cohort of seven patients were male, while three were female. All individuals underwent successful surgery, with the closure of MH postoperatively. Swept-source optical coherence tomography was used to examine the closure of the MH on the first day after surgery, which was further validated by the absorption of gas. Over 12 months, the mean best corrected visual acuity in the logarithm of the minimum angle of resolution (Log MAR) improved significantly, progressing from 1.60 to 0.60. This favorable trend persisted throughout the 12-month follow-up, with MH remaining consistently closed. One patient encountered a subsequent retinal re-detachment, necessitating prompt and effective surgical intervention, resulting in successful management.
conclusionAn autologous ILM transplant with a 27G+ PPV is a delicate and effective technique for closing MH in complicated cases. We recommend this technique for failed and recurrent MH in different pathologies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.